2008
DOI: 10.1016/j.taap.2008.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Factors affecting toxicity and efficacy of polymeric nanomedicines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
55
0
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(56 citation statements)
references
References 40 publications
0
55
0
1
Order By: Relevance
“…Hence, the increasing applications of nanoparticles in various fields may lead to an increase in human exposure which in turn may increase direct toxicological effects. Despite apparent advantages of certain nanoparticles and their applications, many undesirable side effects of nano-sized particles have been documented in previous studies over the last decade [12,13].…”
Section: Introductionmentioning
confidence: 99%
“…Hence, the increasing applications of nanoparticles in various fields may lead to an increase in human exposure which in turn may increase direct toxicological effects. Despite apparent advantages of certain nanoparticles and their applications, many undesirable side effects of nano-sized particles have been documented in previous studies over the last decade [12,13].…”
Section: Introductionmentioning
confidence: 99%
“…8 Resolving the problem will significantly improve the bioavailability of targeted nanodrugs, enhancing the delivery of the drug to the targeted lesion site, thus improving its therapeutic effect and reducing side effects. 3,9 The surface modification of NPs by polyethylene glycol (PEG) was developed as the first strategy to prolong NP circulation. While PEGylation has helped prolong particle circulation time, it has several limitations, including the transient nature of the effect and the compromised particle-target interactions.…”
mentioning
confidence: 99%
“…Суттєвою перевагою полімерних носіїв є знижен-ня загальної токсичності ліків та оптимізація фармакокінетичних параметрів їхньої дії [2,3].…”
Section: вступunclassified